/Investor DB

Korea Investment Partners — 2021 Investments

6 investments dated 2021 · listed companies and verified rows first · show all

1939 Games1939games.comin𝕏Sep 2021 · $5.3M

1939 Games develops a digital collectible card game set in a WWII military theme.

Gaming

Gudmundur KristjanssonIvar Kristjanssonin

Co-investorsCrit VenturesCrowberry CapitalSisu Game VenturesSeoul Investment PartnersTencent Holdings

Animoca Brandsanimocabrands.comin𝕏Jul 2021 · $50M

Animoca Brands invests in blockchain and digital asset projects across gaming, infrastructure, culture, and real-world asset categories, with a portfolio of 600+ companies and a focus on Web3 ecosystem development.

B2B MarketplacesCrypto & Web3GamingSector Agnostic

Yat Siu(Founder)Robby YunginDavid J. Kim(Founder)

Co-investors2080 Ventures500 GlobalA'Z AngelsAdit Ventures Management, LlcAlpha Wave GlobalAppWorks Ventures+50 more

GENEOS TherapeuticsinSeries A · Mar 2021 · $12M

BiotechPlymouth Meeting, US

Niranjan Y. Sardesai(Executive Officer, Director)inLaurent Humeau(Director)James Eadie(Director)Samuel Broder(Director)Sangwoo Lee(Director)Casey Cunningham(Director)

Co-investors3B Future Health Fund

OncoMyx TherapeuticsinDec 2021

BiotechPhoenix, US

Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)

Co-investorsXeraya CapitalB Capital GroupBoehringer Ingelheim Venture FundCity Hill VenturesDelos CapitalLumira Ventures+1 more

Rgenta Therapeuticsrgentatx.cominNov 2021

Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)

Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundLilly Asia VenturesMatrix Capital Management+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

PDC*line Pharma

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.